KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Return on Sales (2016 - 2025)

Abbott Laboratories' Return on Sales history spans 17 years, with the latest figure at 0.15% for Q4 2025.

  • For Q4 2025, Return on Sales fell 69.0% year-over-year to 0.15%; the TTM value through Dec 2025 reached 0.15%, down 17.0%, while the annual FY2025 figure was 0.15%, 17.0% down from the prior year.
  • Return on Sales for Q4 2025 was 0.15% at Abbott Laboratories, up from 0.14% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.84% in Q4 2024 and bottomed at 0.1% in Q4 2022.
  • The 5-year median for Return on Sales is 0.15% (2024), against an average of 0.18%.
  • The largest annual shift saw Return on Sales surged 69bps in 2024 before it crashed -69bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.17% in 2021, then crashed by -41bps to 0.1% in 2022, then skyrocketed by 52bps to 0.16% in 2023, then surged by 440bps to 0.84% in 2024, then tumbled by -82bps to 0.15% in 2025.
  • Per Business Quant, the three most recent readings for ABT's Return on Sales are 0.15% (Q4 2025), 0.14% (Q3 2025), and 0.16% (Q2 2025).